| Dr David M Kanar, MD | |
|
10103 Ridgegate Pkwy Ste 202, Lone Tree, CO 80124-5525 | |
| (303) 799-8760 | |
| (303) 799-8767 |
| Full Name | Dr David M Kanar |
|---|---|
| Gender | Male |
| Speciality | Nephrology |
| Experience | 26 Years |
| Location | 10103 Ridgegate Pkwy Ste 202, Lone Tree, Colorado |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316930613 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | 42626 (Colorado) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Heart Of The Rockies Regional Medical Center | Salida, CO | Hospital |
| Uchealth Highlands Ranch Hospital | Highlands ranch, CO | Hospital |
| Sky Ridge Medical Center | Lone tree, CO | Hospital |
| San Luis Valley Health | Alamosa, CO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Salida Hospital District | 3577451152 | 82 |
| Denver Nephrologists Pc | 8729991393 | 52 |
News Archive
Knowing the amount of opioids taken following cesarean section surgery and before discharge can inform individualized prescriptions and cut down on unnecessary, leftover pills that could be used for non-medical purposes, according to a new study from the University of Colorado Anschutz Medical Campus.
Sanofi and its subsidiary Genzyme announced today that the U.S. Food and Drug Administration has approved Lemtrada (alemtuzumab) for the treatment of patients with relapsing forms of multiple sclerosis (MS). Because of its safety profile, the use of Lemtrada should generally be reserved for patients who have had an inadequate response to two or more drugs indicated for the treatment of MS.
Less than three per cent of UK 11-year-olds are taking enough exercise, suggests research published ahead of print in the Archives of Disease in Childhood.
The initial goal was reportedly based on flawed data and the newly set milepost has already been met. Still, The Baltimore Sun reports that the state has halted work on its small business marketplace, and that Maryland will charge for work related to public information requests about what went wrong with the website.
› Verified 8 days ago
| Entity Name | Denver Nephrologists Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598877516 PECOS PAC ID: 8729991393 Enrollment ID: O20031110000465 |
News Archive
Knowing the amount of opioids taken following cesarean section surgery and before discharge can inform individualized prescriptions and cut down on unnecessary, leftover pills that could be used for non-medical purposes, according to a new study from the University of Colorado Anschutz Medical Campus.
Sanofi and its subsidiary Genzyme announced today that the U.S. Food and Drug Administration has approved Lemtrada (alemtuzumab) for the treatment of patients with relapsing forms of multiple sclerosis (MS). Because of its safety profile, the use of Lemtrada should generally be reserved for patients who have had an inadequate response to two or more drugs indicated for the treatment of MS.
Less than three per cent of UK 11-year-olds are taking enough exercise, suggests research published ahead of print in the Archives of Disease in Childhood.
The initial goal was reportedly based on flawed data and the newly set milepost has already been met. Still, The Baltimore Sun reports that the state has halted work on its small business marketplace, and that Maryland will charge for work related to public information requests about what went wrong with the website.
› Verified 8 days ago
| Entity Name | Salida Hospital District |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972778272 PECOS PAC ID: 3577451152 Enrollment ID: O20040413000292 |
News Archive
Knowing the amount of opioids taken following cesarean section surgery and before discharge can inform individualized prescriptions and cut down on unnecessary, leftover pills that could be used for non-medical purposes, according to a new study from the University of Colorado Anschutz Medical Campus.
Sanofi and its subsidiary Genzyme announced today that the U.S. Food and Drug Administration has approved Lemtrada (alemtuzumab) for the treatment of patients with relapsing forms of multiple sclerosis (MS). Because of its safety profile, the use of Lemtrada should generally be reserved for patients who have had an inadequate response to two or more drugs indicated for the treatment of MS.
Less than three per cent of UK 11-year-olds are taking enough exercise, suggests research published ahead of print in the Archives of Disease in Childhood.
The initial goal was reportedly based on flawed data and the newly set milepost has already been met. Still, The Baltimore Sun reports that the state has halted work on its small business marketplace, and that Maryland will charge for work related to public information requests about what went wrong with the website.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr David M Kanar, MD 1000 Rush Dr, Salida, CO 81201-9627 Ph: (719) 530-2000 | Dr David M Kanar, MD 10103 Ridgegate Pkwy Ste 202, Lone Tree, CO 80124-5525 Ph: (303) 799-8760 |
News Archive
Knowing the amount of opioids taken following cesarean section surgery and before discharge can inform individualized prescriptions and cut down on unnecessary, leftover pills that could be used for non-medical purposes, according to a new study from the University of Colorado Anschutz Medical Campus.
Sanofi and its subsidiary Genzyme announced today that the U.S. Food and Drug Administration has approved Lemtrada (alemtuzumab) for the treatment of patients with relapsing forms of multiple sclerosis (MS). Because of its safety profile, the use of Lemtrada should generally be reserved for patients who have had an inadequate response to two or more drugs indicated for the treatment of MS.
Less than three per cent of UK 11-year-olds are taking enough exercise, suggests research published ahead of print in the Archives of Disease in Childhood.
The initial goal was reportedly based on flawed data and the newly set milepost has already been met. Still, The Baltimore Sun reports that the state has halted work on its small business marketplace, and that Maryland will charge for work related to public information requests about what went wrong with the website.
› Verified 8 days ago
Dr. John Paul Wilkins, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 10240 Park Meadows Dr, Lone Tree, CO 80124 Phone: 303-338-4545 | |
Dr. Michael Alan Rocklin, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 9777 S Yosemite St Ste 110, Lone Tree, CO 80124 Phone: 720-696-0852 Fax: 720-696-0892 | |
Dr. Baran Aksut, BARAN AKSUT M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 10103 Ridgegate Pkwy Ste 103, Lone Tree, CO 80124 Phone: 303-645-0090 Fax: 303-645-0092 | |
Dr. James Thomas Link, M. D., PHD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 10240 Park Meadows Dr, Lone Tree, CO 80124 Phone: 303-338-4545 | |
Abigail Turnbough, Nephrology Medicare: Medicare Enrolled Practice Location: 10099 Ridgegate Pkwy Ste 200, Lone Tree, CO 80124 Phone: 720-476-3364 Fax: 720-875-2877 | |
Kenji Kaye, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 9695 S Yosemite St Ste 224, Lone Tree, CO 80124 Phone: 303-265-3970 Fax: 206-320-8048 | |
Dr. Anna K.d. Gutmann, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 10101 Ridgegate Pkwy, Lone Tree, CO 80124 Phone: 303-338-4545 |